XML 87 R29.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Stock Option Valuation Assumptions for Equity Awards and Liability Awards
The fair value of the Company’s stock options granted in 2025 that are being classified as equity awards were estimated using the Black-Scholes option pricing model with the following assumptions and weighted average fair values:
Year Ended
December 31, 2025
Valuation assumptions:
Grant price
$2.41 – $2.60
Exercise price
$2.41 – $2.60
Expected dividend yield0 %
Expected volatility
61.10% – 79.30%
Expected life (in years)
4.28 – 4.38
Risk-free interest rate
3.77% – 3.94%
Schedule of Stock Option Activity
Stock option activity during the periods indicated below was as follows:
Number of
Shares
Subject to
Issuance
Weighted- average Exercise PriceWeighted- average Remaining
Contractual Term		Aggregate Intrinsic Value
Outstanding at December 31, 20231,152,714$3.07 3.18 years$38 
Granted652,9792.00  
Forfeited(472,713)2.42 
Exercised(179,875)1.72 
Outstanding at December 31, 20241,153,105$2.94 3.88 years$536 
Granted596,6512.58 
Forfeited(213,162)2.33 
Exercised(360,173)2.49 
Outstanding at December 31, 20251,176,421$3.00 4.44 years$4,663 
Exercisable at December 31, 2025590,794$3.51 2.55 years$2,208 
Summary of Stock Options
The following is a summary of stock options as of December 31, 2025:
Options OutstandingOptions Exercisable
Range of Exercise PricesNumber of
Options		Weighted-
average
Remaining Life		Weighted-
average
Exercise
Price		Number of
Options		Weighted-
average
Exercise
Price
$1.81 to $2.52
434,4033.68 years$2.08 306,566$2.06 
$2.53 to $11.50
742,0183.81 years$3.55 284,228$5.08 
1,176,4213.75 years$3.00 590,794$3.51 
Schedule of Restricted Stock Unit Activity
Restricted stock unit activity during the periods indicated below is as follows:
Number of
Shares 		Weighted
Average
Grant Date
Fair Value
Outstanding at December 31, 202360,500$4.23 
Granted223,4854.23 
Vested and settled in shares(246,028)2.80 
Outstanding at December 31, 202437,957$2.51 
Granted58,8764.54 
Vested and settled in shares(83,096)3.31 
Outstanding December 31, 202513,737$6.37 
Schedule of Stock-based Compensation Expense
Stock-based compensation expense for the years ended December 31, 2025 and 2024 is as follows:
Years Ended December 31,
20252024
Stock options$509 $467 
Restricted stock units268 409 
$777 $876 
Schedule of Stock-based Compensation Included in Operating Expenses
Stock-based compensation is included in operating expenses as follows:
Years Ended December 31,
20252024
Selling, general and administrative$668 $821 
Research and development109 55 
$777 $876